Theriva Biologics Inc (TOVX)
1.28
+0.02
(+1.59%)
USD |
NYAM |
Nov 21, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Price to Book Value: 0.1446 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 0.1423 |
| November 19, 2024 | 0.1423 |
| November 18, 2024 | 0.1401 |
| November 15, 2024 | 0.1536 |
| November 14, 2024 | 0.1525 |
| November 13, 2024 | 0.1604 |
| November 12, 2024 | 0.1615 |
| November 11, 2024 | 0.2101 |
| November 08, 2024 | 0.2248 |
| November 07, 2024 | 0.2295 |
| November 06, 2024 | 0.2093 |
| November 05, 2024 | 0.2093 |
| November 04, 2024 | 0.2199 |
| November 01, 2024 | 0.2114 |
| October 31, 2024 | 0.1551 |
| October 30, 2024 | 0.1573 |
| October 29, 2024 | 0.1562 |
| October 28, 2024 | 0.1615 |
| October 25, 2024 | 0.1626 |
| October 24, 2024 | 0.1594 |
| October 23, 2024 | 0.1562 |
| October 22, 2024 | 0.1541 |
| October 21, 2024 | 0.1573 |
| October 18, 2024 | 0.1583 |
| October 17, 2024 | 0.1541 |
| Date | Value |
|---|---|
| October 16, 2024 | 0.1551 |
| October 15, 2024 | 0.1477 |
| October 14, 2024 | 0.1472 |
| October 11, 2024 | 0.1604 |
| October 10, 2024 | 0.1658 |
| October 09, 2024 | 0.1753 |
| October 08, 2024 | 0.1636 |
| October 07, 2024 | 0.1732 |
| October 04, 2024 | 0.1785 |
| October 03, 2024 | 0.1902 |
| October 02, 2024 | 0.1318 |
| October 01, 2024 | 0.136 |
| September 30, 2024 | 0.1466 |
| September 27, 2024 | 0.1307 |
| September 26, 2024 | 0.1066 |
| September 25, 2024 | 0.1239 |
| September 24, 2024 | 0.1704 |
| September 23, 2024 | 0.1787 |
| September 20, 2024 | 0.1986 |
| September 19, 2024 | 0.1981 |
| September 18, 2024 | 0.2064 |
| September 17, 2024 | 0.2143 |
| September 16, 2024 | 0.2012 |
| September 13, 2024 | 0.2122 |
| September 12, 2024 | 0.1881 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1066
Minimum
Sep 26 2024
82.15
Maximum
Dec 26 2019
2.201
Average
0.251
Median
Price to Book Value Benchmarks
| Merck & Co Inc | 5.676 |
| Pro-Dex Inc | 4.515 |
| BioCardia Inc | 3.580 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| Price | 1.28 |
| Earnings Yield | -2.59K% |
| Market Cap | 3.561M |